IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 149 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,723,000 | +5.8% | 534,384 | -1.9% | 0.00% | +33.3% |
Q4 2021 | $6,352,000 | +5.0% | 544,769 | +17.6% | 0.00% | 0.0% |
Q3 2021 | $6,049,000 | +25.8% | 463,155 | +24.0% | 0.00% | 0.0% |
Q2 2021 | $4,807,000 | +135.6% | 373,486 | +104.7% | 0.00% | +200.0% |
Q1 2021 | $2,040,000 | -22.0% | 182,431 | -20.5% | 0.00% | -50.0% |
Q4 2020 | $2,614,000 | +47.1% | 229,466 | +16.1% | 0.00% | +100.0% |
Q3 2020 | $1,777,000 | +11.8% | 197,588 | +28.3% | 0.00% | 0.0% |
Q2 2020 | $1,589,000 | +24.5% | 154,009 | +21.8% | 0.00% | 0.0% |
Q1 2020 | $1,276,000 | -51.4% | 126,425 | -35.9% | 0.00% | -50.0% |
Q4 2019 | $2,625,000 | +277.2% | 197,198 | +143.2% | 0.00% | +100.0% |
Q3 2019 | $696,000 | +1.6% | 81,086 | +29.5% | 0.00% | 0.0% |
Q2 2019 | $685,000 | -3.1% | 62,608 | +19.8% | 0.00% | 0.0% |
Q1 2019 | $707,000 | +39.7% | 52,255 | +6.9% | 0.00% | 0.0% |
Q4 2018 | $506,000 | -63.8% | 48,886 | -35.5% | 0.00% | 0.0% |
Q3 2018 | $1,399,000 | -11.2% | 75,787 | -8.1% | 0.00% | 0.0% |
Q2 2018 | $1,576,000 | +45.0% | 82,448 | +17.1% | 0.00% | 0.0% |
Q1 2018 | $1,087,000 | -5.7% | 70,417 | -8.5% | 0.00% | 0.0% |
Q4 2017 | $1,153,000 | +12.6% | 76,937 | +18.5% | 0.00% | 0.0% |
Q3 2017 | $1,024,000 | -15.4% | 64,930 | +1.3% | 0.00% | 0.0% |
Q2 2017 | $1,211,000 | -12.1% | 64,121 | -20.5% | 0.00% | -50.0% |
Q1 2017 | $1,377,000 | +15.8% | 80,693 | +3.7% | 0.00% | 0.0% |
Q4 2016 | $1,189,000 | +24.0% | 77,780 | +28.8% | 0.00% | +100.0% |
Q3 2016 | $959,000 | +21.4% | 60,386 | -0.0% | 0.00% | 0.0% |
Q2 2016 | $790,000 | +33.0% | 60,395 | +11.3% | 0.00% | 0.0% |
Q1 2016 | $594,000 | +18.6% | 54,255 | +25.5% | 0.00% | 0.0% |
Q4 2015 | $501,000 | -11.8% | 43,237 | -20.6% | 0.00% | 0.0% |
Q3 2015 | $568,000 | -25.9% | 54,487 | -14.4% | 0.00% | 0.0% |
Q2 2015 | $767,000 | -39.5% | 63,631 | -19.7% | 0.00% | -66.7% |
Q1 2015 | $1,268,000 | +16.7% | 79,222 | +11.6% | 0.00% | +50.0% |
Q4 2014 | $1,087,000 | +69.8% | 70,977 | +43.7% | 0.00% | +100.0% |
Q3 2014 | $640,000 | -19.2% | 49,405 | -4.4% | 0.00% | -50.0% |
Q2 2014 | $792,000 | +160.5% | 51,679 | +109.2% | 0.00% | +100.0% |
Q1 2014 | $304,000 | +49.8% | 24,698 | +41.1% | 0.00% | – |
Q4 2013 | $203,000 | +33.6% | 17,507 | +36.2% | 0.00% | – |
Q3 2013 | $152,000 | +47.6% | 12,854 | +23.8% | 0.00% | – |
Q2 2013 | $103,000 | – | 10,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |